In very large quantities, goitrogens can cause a goiter or an enlarged thyroid. They can also act like antithyroid drugs, slowing down your underactive thyroid and potentially causing hypothyroidism.

There are several menstrual problems associated with hypothyroidism, including: The first-line treatment for hypothyroidism is the thyroid hormone replacement medication Levoxyl (levothyroxine). This ...

When the thyroid isn’t functioning properly, it can have a significant impact on overall health and quality of life. Rachel Houdek is a pharmacist at Lewis Drug, and she was here to help us ...

Jan 29 (Reuters) - Cigna Group (CI.N), opens new tab plans to make changes to help lower out-of-pocket cost of prescription drugs, the company said on Wednesday, as it responds to criticism over ...

The report shows that PBMs made over $7.3 billion in extra profits from dispensing specialty generic drugs during the study period. These PBM middlemen, who should be lowering costs, are instead ...

President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for lowering drug costs. Trump’s action didn’t affect the caps on seniors ...

taking too much or too little thyroid medication, and having high stress levels. Research suggests that taking high doses of biotin may lead to inaccurate thyroid test results. The exact amount of ...

US drug prices have soared over the last several decades, causing, at times, financial hardship for patients and their families, so Cuban says he developed MCCPDC with a simple mission – “to ...

One of those now-cancelled policies directed Medicare to investigate ways to slash drug costs, including the possibility of a $2 monthly out-of-pocket cap on some generic medications. HealthDay News — ...

Cigna Group plans to limit patients’ out-of-pocket expenses for medications as the insurer faces pressure from Washington over its role in prescription costs. The changes aim to ensure that ...

Also among the more notable orders reversed was one from President Joe Biden in 2022 that sought to boost efforts to lower prescription drug costs for people covered by Medicare and Medicaid.